1151P Evolution of biomarker testing among non-squamous/non-small cell lung cancer (NSCLC) patients (Pts) and impact on turnaround times (TAT)Zixin Fan, R. Tudor, L. Le et al.|Annals of Oncology|2022Cited by 0